News

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...
Similarly, SKF, a Swedish multinational known for industrial and automotive solutions, operates its Global Technical Centre ...
About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
COPENHAGEN, Denmark, April 29, 2025 /PRNewswire/ -- The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting ...
Copenhagen, Denmark: The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the ...